51 (Suppl 1): S355
These observations suggest that SIRT1, through inhibition of the NLRP3 inflammasome, can mitigate PD neuropathology
[26] Cesta CE, Rotem R, Bateman BT, et al
Originally developed by researchers at Washington State University, it was designed to explore the cognitive role of the AT4 receptor
21 Takeaways As more patients use GLP-1 drugs, it is important for optometrists to be aware of the risks of ophthalmic complications from these medications

The findings established Ipamorelin's defining characteristic: Growth hormone Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Cortisol No significant cortisol elevation was observed with Ipamorelin, while GHRP-2 and GHRP-6 produced measurable cortisol increases Prolactin No significant prolactin elevation at GH-effective concentrations ACTH No significant ACTH stimulation, contrasting with the adrenocorticotropic effects of other GHRPs GHRP Selectivity Comparison (Preclinical Data) Compound GH Release Cortisol Effect Prolactin Effect ACTH Effect Ipamorelin Dose-dependent Minimal / none Minimal / none Minimal / none GHRP-2 Dose-dependent Moderate increase Moderate increase Moderate increase GHRP-6 Dose-dependent Moderate increase Moderate increase Moderate increase Hexarelin Strong Significant increase Significant increase Significant increase Data adapted from Raun et al